Sponsor Dossier
Emcure Pharmaceuticals
Sponsor Dossier for Emcure Pharmaceuticals. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: AMIKACIN
- Brand: ARX-FLECAINIDE
- Brand: BICNU
- Brand: EMEXED
- Brand: EMPOVIR
- Brand: Flec-EM
- Brand: FLECAINIDE-WGR
- Brand: MELPHA
About
Emcure Pharmaceuticals is an Australian Private Company with ABN 47606490797, registered in NSW and currently active.
Portfolio
Emcure Pharmaceuticals has 12 brands on the ARTG, of which 9 are indexable and 9 carry a Product Information document. 0 brands are PBS-listed, 0 have a PBAC outcome on record, and 0 have an AusPAR on record. Notable brands include AMIKACIN, ARX-FLECAINIDE, BICNU, EMEXED, EMPOVIR, Flec-EM, FLECAINIDE-WGR, MELPHA, NITROFURANTOIN EM, NITROPRUSSIDE-EMC, PENTAMIDINE-EMC, Teri-EM.
Therapeutic focus
— Cardiology: 4 brands — Infectious Disease: 4 brands — Oncology: 3 brands — Neurology: 1 brand